Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Liver International : Official Journal of the International Association for the Study of the Liver|August 13, 2008
Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival - an 18-year experienceRupesh Rajani, Tor Melin, Einar Björnsson, et al.
Alimentary Pharmacology & Therapeutics|July 21, 2021
Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality registerIsabella Visuri, Carl Eriksson, Ola Olén, et al.
Scandinavian Journal of Gastroenterology|March 1, 2007
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in ScandinaviaTryggve Ljung, Ole Østergaard Thomsen, Morten Vatn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 9, 2021
Obesity is Associated With Increased Risk of Crohn's disease, but not Ulcerative Colitis: A Pooled Analysis of Five Prospective Cohort StudiesSimon S M Chan, Ye Chen, Kevin Casey, et al.
Therapeutic Advances in Gastroenterology|June 5, 2023
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension studyIsabella Visuri, Carl Eriksson, Sara Karlqvist, et al.
Scandinavian Journal of Gastroenterology|September 10, 2019
Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality registerJonas F Ludvigsson, Marie Andersson, Jonas Bengtsson, et al.
Therapeutic Advances in Gastroenterology|July 19, 2021
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH studyCarl Eriksson, Sara Rundquist, Vyron Lykiardopoulos, et al.
Journal of Crohn'S & Colitis|January 27, 2018
Fibre intake and the development of inflammatory bowel disease: A European prospective multi-centre cohort study (EPIC-IBD)Vibeke Andersen, Simon Chan, Robert Luben, et al.
Pageof 5